ATRYS HEALTH (Germany) Today

A2T Stock  EUR 2.92  0.01  0.34%   

Performance

4 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 48

 
High
 
Low
About Average
ATRYS HEALTH is trading at 2.92 as of the 18th of December 2024. This is a 0.34% down since the beginning of the trading day. The stock's lowest day price was 2.72. ATRYS HEALTH has 48 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. The performance scores are derived for the period starting the 19th of September 2024 and ending today, the 18th of December 2024. Click here to learn more.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH is traded on Frankfurt Stock Exchange in Germany. More on ATRYS HEALTH SA
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

ATRYS Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ATRYS HEALTH's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ATRYS HEALTH or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic IdeaHealth Management (View all Themes)
Business ConcentrationHealth Management, Biotechnology, Healthcare (View all Sectors)
ATRYS HEALTH SA (A2T) is traded on Frankfurt Exchange in Germany and employs 2,397 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 330.53 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ATRYS HEALTH's market, we take the total number of its shares issued and multiply it by ATRYS HEALTH's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ATRYS HEALTH SA classifies itself under Healthcare sector and is part of Biotechnology industry. ATRYS HEALTH SA has accumulated about 17.6 M in cash with (1.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51.
Check ATRYS HEALTH Probability Of Bankruptcy

ATRYS HEALTH SA Risk Profiles

Although ATRYS HEALTH's alpha and beta are two of the key measurements used to evaluate ATRYS HEALTH's performance over the market, the standard measures of volatility play an important role as well.

ATRYS Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in ATRYS HEALTH without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Search Now

   

Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Other Information on Investing in ATRYS Stock

ATRYS HEALTH financial ratios help investors to determine whether ATRYS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ATRYS with respect to the benefits of owning ATRYS HEALTH security.